Hints and tips:
...Paul Pennock, a lawyer at Morgan, said the drugs had caused debilitating and disabling injuries to the firm’s clients, who had not been adequately warned by Lilly and Novo about the dangers of gastroparesis...
...Back then, “profits for many companies were pipe dreams, not reality”, said Liz Ann Sonders, chief investment strategist at Charles Schwab....
...Morgan & Morgan, a personal injury law firm, said on Wednesday it had filed a case on behalf of a 44-year-old woman from Louisiana who suffered such severe vomiting after taking the drugs Ozempic and Mounjaro...
...Its non-tech winners included Apollo Global, Eli Lilly, Airbus and online gambling company Flutter....
...Morgan Stanley says AI could cut pre-clinical development costs by as much as two-fifths. It could create a $50bn market over the next decade....
...Morgan Stanley recently increased its estimate for the size of the obesity drugs market from $54bn to $77bn by the end of the decade....
...Banks such as Goldman Sachs and Morgan Stanley are leading the charge, Bloomberg writes....
...Investment banker Mike Kenworthy, who focuses on software deals and sports deals, is joining Morgan Stanley, while Brian Bolster, who leads natural resources investment banking in the Americas, is retiring...
...Inspired by tales of celebrities’ dramatic weight loss, people are expected to widely adopt the weight-loss drugs — soon to be joined by Eli Lilly’s Mounjaro — potentially leading to seismic shifts in consumer...
...Citi applied for a licence to run a mainland investment banking unit back in 2021, months after rivals Goldman Sachs, Morgan Stanley and JPMorgan took full control of their own units in the country....
...Bank of America, Morgan Stanley, BNY Mellon, Charles Schwab, and PNC Financial Services also release earnings. Lockheed Martin is among the non-financial companies reporting....
...Colocci joined Morgan Stanley in 2004 as a managing director. He left for JPMorgan Chase in 2017 before returning in 2019....
...His rival at Morgan Stanley, James Gorman, is stepping down at the end of the year, to be replaced by Ted Pick, who currently runs investment banking and trading....
...Goldman Sachs and Morgan Stanley were among the earliest businesses to order a return to the office....
...Investors believe they will win: Morgan Stanley this week suggested that pills will attract people put off by injections, and global obesity drug sales could exceed $50bn by 2030....
...Eli Lilly, whose diabetes drug tirzepatide should get regulatory approval to treat weight loss this year, has risen 19 per cent....
...This is the case with Eli Lilly, based in Indiana....
...Morgan Stanley forecasts Novo Nordisk and Lilly will capture about 40 per cent of the market, as they develop and launch up to a dozen obesity medicines currently in development between them....
...It also signed a partnership with Lilly to develop treatments for the same disease....
...Pharmaceutical companies Eli Lilly, Merck and Bristol Myers Squibb also report....
...Clare Woodman, head of Emea for Morgan Stanley, said that the Edinburgh reforms should increase UK financial market efficiency and competitiveness overall....
...“I watched him build his empire and, by the way, it is an empire,” said Mary Ann Tighe, chief executive of another real estate firm CBRE’s New York office....
...So Jae-Ann Maher, who is on the record in our article, you know, an amazing woman who’s been incredibly brave, said that she was working near Crispin’s desk and he instructed her to come sit next to him....
International Edition